TAMs can recognize dying tumor cells through the MER tyrosine-protein kinase (MERTK) receptor and upregulate the expression of wound-healing factors such as TGF-β, IL-10, and ARG1 that suppress anti-tumor immunity (113). Here, MERTK is linked to neoplasm.